Cinnamon extract improves insulin sensitivity in the brain and lowers liver fat in mouse models of obesity

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Sartorius, Tina ^a,b   Peter, Andreas ^a   Schulz, Nadja ^b,c   Drescher, Andrea ^a   Bergheim, Ina ^d   MacHann, Jürgen ^a,b   Schick, Fritz ^a   Siegel Axel, Dorothea ^a   Schürmann, Annette ^b,c   Weigert, Cora ^a,b   Häring, Hans Ulrich ^a,b   Hennige, Anita M ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^c GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CINNAMALDEHYDE; CINNAMOMUM ZEYLANICUM EXTRACT; EUGENOL; GLUCOSE; GLYCOGEN; INSULIN; LIVER PROTECTIVE AGENT; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ACROLEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; ASTROCYTE; BRAIN FUNCTION; CINNAMOMUM ZEYLANICUM; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; ENERGY EXPENDITURE; FATTY LIVER; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLYCOGEN ANALYSIS; GLYCOGEN SYNTHESIS; HORMONE ACTION; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; INSULIN SENSITIVITY; LIVER PROTECTION; LOCOMOTION; MALE; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; BRAIN; C57BL MOUSE; CALORIC INTAKE; CELL LINE; CHEMISTRY; DRUG EFFECTS; HUMAN; INSULIN RESISTANCE; LIVER; METABOLISM; MOTOR ACTIVITY; MOUSE MUTANT; OBESITY; PHYSIOLOGY;

ACROLEIN; ADIPOSITY; ANIMALS; ASTROCYTES; BRAIN; CELL LINE; CINNAMOMUM ZEYLANICUM; ENERGY INTAKE; EUGENOL; GLYCOGEN; HUMANS; INSULIN; INSULIN RESISTANCE; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; MOTOR ACTIVITY; OBESITY; PLANT EXTRACTS;

EID: 84898665573     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092358     Document Type: Article

References (54)

1. Gruenwald J, Freder J, Armbruester N (2010) Cinnamon and health. Crit Rev Food Sci Nutr 50: 822-834.
2. Cai Y, Luo Q, Sun M, Corke H (2004) Antioxidant activity and phenolic compounds of 112 traditional Chines (Pubitemid 38210440)
3. Ho YS, So KF, Chang RC (2010) Anti-aging herbal medicine-how and why can they be used in aging-associated neurodegenerative diseases? Ageing Res Rev 9: 354-362.
4. Altschuler JA, Casella SJ, MacKenzie TA, Curtis KM (2007) The effect of cinnamon on A1C among adolescents with type 1 diabetes. Diabetes Care 30: 813-816. (Pubitemid 46556572)
5. Vuksan V, Sievenpiper JL (2005) Herbal remedies in the management of diabetes: lessons learned from the study of ginseng. Nutr Metab Cardiovasc Dis 15: 149-160. (Pubitemid 40934158)
6. Anand P, Murali KY, Tandon V, Murthy PS, Chandra R (2010) Insulinotropic effect of cinnamaldehyde on transcriptional regulation of pyruvate kinase, phosphoenolpyruvate carboxykinase, and GLUT4 translocation in experimental diabetic rats. Chem Biol Interact 186: 72-81.
7. Davis PA, Yokoyama W (2011) Cinnamon intake lowers fasting blood glucose: meta-analysis. J Med Food 14: 884-889.
8. Lu T, Sheng H, Wu J, Cheng Y, Zhu J, et al. (2012) Cinnamon extract improves fasting blood glucose and glycosylated hemoglobin level in Chinese patients with type 2 diabetes. Nutr Res 32: 408-412.
9. Suppapitiporn S, Kanpaksi N, Suppapitiporn S (2006) The effect of cinnamon cassia powder in type 2 diabetes mellitus. J Med Assoc Thai 89 Suppl 3: S200-S205.
10. Frydman-Marom A, Levin A, Farfara D, Benromano T, Scherzer-Attali R, et al. (2011) Orally administrated cinnamon extract reduces beta-amyloid oligomer-ization and corrects cognitive impairment in Alzheimer's disease animal models. PLoS One 6: e16564.
11. Peterson DW, George RC, Scaramozzino F, LaPointe NE, Anderson RA, et al. (2009) Cinnamon extract inhibits tau aggregation associated with Alzheimer's disease in vitro. J Alzheimers Dis 17: 585-597.
12. Shimada Y, Goto H, Kogure T, Kohta K, Shintani T, et al. (2000) Extract prepared from the bark of Cinnamomum cassia Blume prevents glutamate-induced neuronal death in cultured cerebellar granule cells. Phytother Res 14: 466-468.
13. Plum L, Belgardt BF, Bruning JC (2006) Central insulin action in energy and glucose homeostasis. J Clin Invest 116: 1761-1766. (Pubitemid 44033295)
14. Obici S, Zhang BB, Karkanias G, Rossetti L (2002) Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 8: 1376-1382. (Pubitemid 36019422)
15. Milanski M, Arruda AP, Coope A, Ignacio-Souza LM, Nunez CE, et al. (2012) Inhibition of hypothalamic inflammation reverses diet-induced insulin resistance in the liver. Diabetes 61: 1455-1462.
16. Wickenberg J, Lindstedt S, Berntorp K, Nilsson J, Hlebowicz J (2012) Ceylon cinnamon does not affect postprandial plasma glucose or insulin in subjects with impaired glucose tolerance. Br J Nutr 107: 1845-1849.
17. Hennige AM, Sartorius T, Lutz SZ, Tschritter O, Preissl H, et al. (2009) Insulinmediated cortical activity in the slow frequency range is diminished in obese mice and promotes physical inactivity. Diabetologia 52: 2416-2424.
18. Sartorius T, Ketterer C, Kullmann S, Balzer M, Rotermund C, et al. (2012) Monounsaturated fatty acids prevent the aversive effects of obesity on locomotion, brain activity, and sleep behavior. Diabetes 61: 1669-1679.
19. Tschritter O, Preissl H, Hennige AM, Stumvoll M, Porubska K, et al. (2006) The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: a magnetoencephalographic study. Proc Natl Acad Sci U S A 103: 12103-12108. (Pubitemid 44215818)
20. Tschritter O, Preissl H, Hennige AM, Sartorius T, Grichisch Y, et al. (2009) The insulin effect on cerebrocortical theta activity is associated with serum concentrations of saturated nonesterified Fatty acids. J Clin Endocrinol Metab 94: 4600-4607.
21. Sartorius T, Heni M, Tschritter O, Preissl H, Hopp S, et al. (2012) Leptin affects insulin action in astrocytes and impairs insulin-mediated physical activity. Cell Physiol Biochem 30: 238-246.
22. Ranasinghe P, Jayawardana R, Galappaththy P, Constantine GR, de Vas GN, et al. (2012) Efficacy and safety of 'true' cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: a systematic review and meta-analysis. Diabet Med 29: 1480-1492.
23. Lungarini S, Aureli F, Coni E (2008) Coumarin and cinnamaldehyde in cinnamon marketed in Italy: a natural chemical hazard? Food Addit Contam Part A Chem Anal Control Expo Risk Assess 25: 1297-1305.
24. Usta J, Kreydiyyeh S, Bajakian K, Nakkash-Chmaisse H (2002) In vitro effect of eugenol and cinnamaldehyde on membrane potential and respiratory chain complexes in isolated rat liver mitochondria. Food Chem Toxicol 40: 935-940. (Pubitemid 34626701)
25. Usta J, Kreydiyyeh S, Barnabe P, Bou-Moughlabay Y, Nakkash-Chmaisse H.(2003) Comparative study on the effect of cinnamon and clove extracts and their main components on different types of ATPases. Hum Exp Toxicol 22: 355-362. (Pubitemid 36987229)
26. Chericoni S, Prieto JM, Iacopini P, Cioni P, Morelli I (2005) In vitro activity of the essential oil of Cinnamomum zeylanicum and eugenol in peroxynitrite-induced oxidative processes. J Agric Food Chem 53: 4762-4765. (Pubitemid 40937594)
27. Simic A, Soković MD, Ristić M, Grujić-Jovanović S, Vukojević J, et al. (2004) The chemical composition of some Lauraceae essential oils and their antifungal activities. Phytother Res 18: 713-717. (Pubitemid 39481689)
28. Singh G, Maurya S, DeLampasona MP, Catalan CA. (2007) A comparison of chemical, antioxidant and antimicrobial studies of cinnamon leaf and bark volatile oils, oleoresins and their constituents. Food Chem Toxicol 45: 1650-1661. (Pubitemid 47102502)
29. Zlokovic BV (2008) The blood-brain barrier in health and chronic neurode-generative disorders. Neuron 57: 178-201.
30. Pfeiffer-Guglielmi B, Fleckenstein B, Jung G, Hamprecht B (2003) Immunocy-tochemical localization of glycogen phosphorylase isozymes in rat nervous tissues by using isozyme-specific antibodies. J Neurochem 85: 73-81. (Pubitemid 36389696)
31. Brown AM, Tekkök SB, Ransom BR (2003) Glycogen regulation and functional role in mouse white matter. J Physiol 549: 501-12. (Pubitemid 36701761)
32. Choi IY, Seaquist ER, Gruetter R (2003) Effect of hypoglycemia on brain glycogen metabolism in vivo. J Neurosci Res 72: 25-32. (Pubitemid 36373808)
33. Heni M, Hennige AM, Peter A, Siegel-Axel D, Ordelheide AM, et al. (2011) Insulin promotes glycogen storage and cell proliferation in primary human astrocytes. PLoS One 6: e21594.
34. Sartorius T, Lutz SZ, Hoene M, Waak J, Peter A, et al. (2012) Toll-like receptors 2 and 4 impair insulin-mediated brain activity by interleukin-6 and osteopontin and alter sleep architecture. FASEB J 26: 1799-1809.
35. Hennige AM, Sartorius T, Tschritter O, Preissl H, Fritsche A, et al. (2006) Tissue selectivity of insulin detemir action in vivo. Diabetologia 49: 1274-1282.
36. Machann J, Thamer C, Schnoedt B, Haap M, Haring HU, et al. (2005) Standardized assessment of whole body adipose tissue topography by MRI. J Magn Reson Imaging 21: 455-462. (Pubitemid 40446442)
37. Hennige AM, Burks DJ, Ozcan U, Kulkarni RN, Ye J, et al. (2003) Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes. J Clin Invest 112: 1521-1532. (Pubitemid 38056278)
38. Hennige AM, Lehmann R, Weigert C, Moeschel K, Schauble M, et al. (2005) Insulin glulisine: insulin receptor signaling characteristics in vivo. Diabetes 54: 361-366.
39. Chan TM, Exton JH (1976) A rapid method for the determination of glycogen content and radioactivity in small quantities of tissue or isolated hepatocytes. Anal Biochem 71: 96-105.
40. Stefan N, Kantartzis K, Haring HU (2008) Causes and metabolic consequences of Fatty liver. Endocr Rev 29: 939-960.
41. Rafehi H, Ververis K, Karagiannis TC (2012) Controversies surrounding the clinical potential of cinnamon for the management of diabetes. Diabetes Obes Metab 14: 493-499.
42. Roussel AM, Hininger I, Benaraba R, Ziegenfuss TN, Anderson RA (2009) Antioxidant effects of a cinnamon extract in people with impaired fasting glucose that are overweight or obese. J Am Coll Nutr 28: 16-21.
43. Khan A, Safdar M, Ali Khan MM, Khattak KN, Anderson RA (2003) Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 26: 3215-3218. (Pubitemid 37466877)
44. Saur L, Baptista PP, de Senna PN, Paim MF, Nascimento PD, et al. (2013) Physical exercise increases GFAP expression and induces morphological changes in hippocampal astrocytes. Brain Struct Funct 219: 293-302.
45. Tsou RC, Bence KK (2013) Central regulation of metabolism by protein tyrosine phosphatases. Front Neurosci 6: 192.
46. Yu IC, Lin HY, Liu NC, Sparks JD, Yeh S, et al. (2013) Neuronal androgen receptor regulates insulin sensitivity via suppression of hypothalamic NF-kB-mediated PTP1B expression. Diabetes 62: 411-23.
47. Wie MB, Won MH, Lee KH, Shin JH, Lee JC, et al. (1997) Eugenol protects neuronal cells from excitotoxic and oxidative injury in primary cortical cultures. Neurosci Lett 225: 93-96.
48. Nagababu E, Rifkind JM, Boindala S, Nakka L (2010) Assessment of antioxidant activity of eugenol in vitro and in vivo. Methods Mol Biol 610: 165-180.
49. Kleinridders A, Konner AC, Bruning JC (2009) CNS-targets in control of energy and glucose homeostasis. Curr Opin Pharmacol 9: 794-804.
50. Kantartzis K, Machann J, Schick F, Fritsche A, Haring HU, et al. (2010) The impact of liver fat vs visceral fat in determining categories of prediabetes. Diabetologia 53: 882-889.
51. Couturier K, Qin B, Batandier C, Awada M, Hininger-Favier I, et al. (2011) Cinnamon increases liver glycogen in an animal model of insulin resistance. Metabolism 60: 1590-1597.
52. Inoue H, Ogawa W, Asakawa A, Okamoto Y, Nishizawa A, et al. (2006) Role of hepatic STAT3 in brain-insulin action on hepatic glucose production. Cell Metab 3: 267-275.
53. Deepa B, Venkatraman Anuradha C (2013) Effects of linalool on inflammation, matrix accumulation and podocyte loss in kidney of streptozotocin-induced diabetic rats. Toxicol Mech Methods 23:223-34.
54. Sebai H, Selmi S, Rtibi K, Souli A, Gharbi N, et al. (2013) Lavender (Lavandula stoechas L.) essential oils attenuate hyperglycemia and protect against oxidative stress in alloxan-induced diabetic rats. Lipids Health Dis 12:189.